Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01885351 · ClinicalTrials.gov registry record · NA

An Interactive Preventive Health Record to Increase Colorectal Cancer Screening

A NA study, sponsored by Temple University.

Completed
Registry status
NA
Development phase
683
Enrollment target

NCT01885351: Completed NA study, sponsored by Temple University.

NCT01885351 is a NA study that has completed, run by Temple University. The registered enrollment target is 683 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01885351, a NA study, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
683 participants
Enrollment target

Study Summary

This study involves 3 phases that modifies current Interactive Preventative Health Record-Colorectal Cancer Screening (IPHR-CRCS) modules to address each patient's individual colorectal cancer screening (CRCS) knowledge, attitudes, preferences, and test-specific barriers. The study will engage patients, ages 50-75 years who are non-adherent to CRCS, to assess their CRCS test preferences and corresponding test-specific barriers in "real time". Based on patient characteristics (e.g. age, personal and family history, physician CRCS recommendation, CRCS test preferences, top test-specific barriers), tailored messages/videos will appear in the pop-up screens to address/reduce the top patient-reported, test-specific CRCS barriers while incorporating an action plan for CRCS adherence. The investigators hypothesize that modifying the IPHR-CRCS module to address each patient's individual CRCS knowledge, attitudes, preferences, and test-specific barriers will further increase CRCS.

Primary Outcome

Having had ≥1 test (i.e., fecal occult blood test, sigmoidoscopy, colonoscopy and barium enema) within the time frame specified for each procedure will count as adherent CRCS.

Interventions

  • BEHAVIORAL MyCRCS+Prefs
  • BEHAVIORAL MyCRCS+Prefs+Barriers

Trial Details

FieldValue
Enrollment Target 683 participants
Start Date 2013-03-01
Est. Completion 2020-08-10
Phase NA
Temple University

163 total trials

What the finished NCT01885351 record still lists

NCT01885351 is an interventional study that assigns participants to a tested intervention. The registered 683 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower).

The record links to 0 conditions, and to 2 interventions - of which MyCRCS+Prefs is the first listed.

NCT01885351 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01885351 about?

NCT01885351 is a clinical study titled "An Interactive Preventive Health Record to Increase Colorectal Cancer Screening". This study involves 3 phases that modifies current Interactive Preventative Health Record-Colorectal Cancer Screening (IPHR-CRCS) modules to address each patient's individual colorectal cancer screening (CRCS) knowledge, attitudes, preferences, and test-specific barriers. The study will engage patie...

What is the current status of trial NCT01885351?

This trial is currently completed. It is a NA study. The enrollment target is 683 participants. The study started on 2013-03-01. Estimated completion is 2020-08-10.

What interventions are being tested in trial NCT01885351?

The interventions under investigation include: MyCRCS+Prefs (BEHAVIORAL), MyCRCS+Prefs+Barriers (BEHAVIORAL).

Who is sponsoring clinical trial NCT01885351?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01885351's enrollment target sits among peer trials

683 151st of 2000 higher than 1,850 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06795087 · 684 participants

    Discharge Medication Use Post-Operatively in GU Cancer Patients

  • NCT05099770 · 685 participants · Phase 3

    Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

  • NCT05880199 · 685 participants

    BSGM to Evaluate Patients With GI Symptoms

  • NCT05382559 · 681 participants · Phase 1

    A Study of ASP3082 in Adults With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01885351, the US trial registry maintained by the National Library of Medicine. NCT01885351 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.